3 Top AI-Powered Biotech Stocks to Buy in February
Here are three fantastic biotech stocks harnessing the power of AI that could make a great addition to your portfolio. The ...
Vaxcyte enters final stage of Phase II pneumococcal vaccine trial in infants
VAX-31’s safety, tolerability, and immunogenicity are being assessed in this trial on healthy infants. Vaxcyte anticipat ...
News Medical12h
New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
South Bridge Connector design talks slow; construction remains on schedule
A new bridge over the Fox River is slated for completion by 2030. Designers are still determining the future bridge's ...
Next-generation mRNA vaccine delivery system uses biodegradable polymers
A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.
Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
STAT23h
Personalized cancer vaccine shows potential in kidney cancer
In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.